Novel histamine H₄ receptor ligands and their potential therapeutic applications: an update

Bibliography

• Kollmeier A, Francke K, Chen B, et al. The Histamine H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 2014;350:181-7
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Chen B, Dunford PJ, et al. Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 2014;349:176-84
   PubMed Web of Science ®Google Scholar
• Kiss R, Keserű GM. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 2012;22:205-21
   PubMed Web of Science ®Google Scholar
• Clinical trial: a Study of JNJ-38518168 in symptomatic adult participants with uncontrolled, persistent asthma. 2014. Available from: http://clinicaltrials.gov/show/NCT01823016 [Last accessed 20 July 2014]
   Google Scholar
• Clinical trial: a dose range finding study of JNJ-38518168 in patients with active rheumatoid arthritis in spite of treatment with methotrexate. 2014. Available from: http://clinicaltrials.gov/show/NCT01679951 [Last accessed 20 July 2014]
   Google Scholar
• ZIARCO, histamine H4 receptor antagonist programme. 2014. Available from: http://ziarcopharma.com/h4.html [Last accessed 20 July 2014]
   Google Scholar
• Kalypsys. 2014. Available from: http://www.kalypsys.com/home/home01.shtml [Last accessed 20 July 2014]
   Google Scholar
• Draconis Pharma. 2014. Available from: http://draconispharma.com/index.php/en/history [Last accessed 20 July 2014]
   Google Scholar
• Jemima EA, Prema A, Thangam EB. Functional characterization of histamine H4 receptor on human mast cells. Mol Immunol 2014;62:19-28
   PubMed Web of Science ®Google Scholar
• Neumann D, Seifert R. The therapeutic potential of histamine receptor ligands in inflammatory bowel disease. Biochem Pharmacol 2014;91(1):12-17
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Albrecht M, Behrens B, et al. Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammation. PLoS One 2014;9:e87296
   Web of Science ®Google Scholar
• Czerner CP, Klos A, Seifert R, et al. Histamine induces chemotaxis and phagocytosis in murine bone marrow-derived macrophages and RAW 264.7 macrophage-like cells via histamine H4-receptor. Inflamm Res 2014;63:239-47
   PubMed Web of Science ®Google Scholar
• Cowden JM, Yu F, Banie H, et al. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis 2014;73:600-8
   PubMed Web of Science ®Google Scholar
• Cowden JM, Yu F, Challapalli M, et al. Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo. Inflamm Res 2013;62:599-607
   PubMed Web of Science ®Google Scholar
• Somma T, Cinci L, Formicola G, et al. A selective antagonist of histamine H4 receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1. Br J Pharmacol 2013;170:200-13
   PubMed Web of Science ®Google Scholar
• Neumann D, Beermann S, Burhenne H, et al. The dual H3/4R antagonist thioperamide does not fully mimic the effects of the ’standard’ H4R antagonist JNJ 7777120 in experimental murine asthma. Naunyn Schmiedebergs Arch Pharmacol 2013;386:983-90
   PubMed Web of Science ®Google Scholar
• Ballerini C, Aldinucci A, Luccarini I, et al. Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 2013;170:67-77
   PubMed Web of Science ®Google Scholar
• Glatzer F, Gschwandtner M, Ehling S, et al. Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J Allergy Clin Immunol 2013;132:1358-67
   PubMed Web of Science ®Google Scholar
• Suwa E, Yamaura K, Sato S, et al. Increased expression of the histamine H4 receptor following differentiation and mediation of the H4 receptor on interleukin-8 mRNA expression in HaCaT keratinocytes. Exp Dermatol 2014;23:138-40
   PubMed Web of Science ®Google Scholar
• Yu B, Shao Y, Zhang J, et al. Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis. Br J Dermatol 2010;162:1038-43
   PubMed Web of Science ®Google Scholar
• Mommert S, Scherer R, Glatzer F, et al. Genetic variants in the promoter region of the human histamine H4 receptor gene are associated with psoriasis. J Invest Dermatol 2013;133:S134
   Web of Science ®Google Scholar
• Janssen. Use of a histamine H4 antagonist for the treatment of post-operative adhesions. US20130202685A1; 2013
   Google Scholar
• Matsushita A, Seike M, Okawa H, et al. Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 2012;21:714-15
   PubMed Web of Science ®Google Scholar
• Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 2012;67:1014-22
   PubMed Web of Science ®Google Scholar
• Deiteren A, De Man JG, Ruyssers NE, et al. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. Gut 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• UCL Business Plc. Histamine 4 receptor partial agonists, inverse agonists or antagonists for use in treating non-autoimmune uveitis. WO20140033480; 2014
   Google Scholar
• Terrasse G. Use of an h4 agonist molecule for treating cystic fibrosis. WO20130175116A1; 2013
   Google Scholar
• Kaneko H, Ye F, Ijima R, et al. Histamine receptor h4 as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 2014;171(15):3754-63
   PubMed Web of Science ®Google Scholar
• Aldi S, Takano K, Tomita K, et al. Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation. J Pharmacol Exp Ther 2014;349:508-17
   PubMed Web of Science ®Google Scholar
• Cai WK, Hu J, Li T, et al. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-beta1 signalling pathway in non-small cell lung cancer. Eur J Cancer 2014;50:1195-206
   PubMed Web of Science ®Google Scholar
• Zhang C, Xiong Y, Li J, et al. Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. PLoS One 2012;7:e31207
   Web of Science ®Google Scholar
• Wersinger E, Gaboyard-Niay S, Travo C, et al. Symptomatic treatment of vestibular deficits: therapeutic potential of histamine H4 receptors. J Vestib Res 2013;23:153-9
   PubMed Web of Science ®Google Scholar
• Desmadryl G, Gaboyard-Niay S, Brugeaud A, et al. Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability. Br J Pharmacol 2012;167:905-16
   PubMed Web of Science ®Google Scholar
• Martinel Lamas DJ, Carabajal E, Prestifilippo JP, et al. Protection of radiation-induced damage to the hematopoietic system, small intestine and salivary glands in rats by JNJ7777120 compound, a histamine H4 ligand. PLoS One 2013;8:e69106
   Web of Science ®Google Scholar
• Galeotti N, Sanna MD, Ghelardini C. Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology 2013;71:141-7
   PubMed Web of Science ®Google Scholar
• Adami M, Pozzoli C, Menozzi A, et al. Effects of histamine H4 receptor ligands in a mouse model of gastric ulceration. Pharmacology 2012;89:287-94
   PubMed Web of Science ®Google Scholar
• Sensorion. H4 receptor inhibitors for treating tinnitus. WO20130182711; 2013
   Google Scholar
• PATENTSCOPE database of World Intellectual Property Organization. 2014. Available from: http://www.wipo.int/patentscope/search/en/structuredSearch.jsf [Last accessed 6 June 2014]
   Google Scholar
• Geyer R, Kaske M, Baumeister P, et al. Synthesis and functional characterization of imbutamine analogues as histamine H3 and H4 receptor ligands. Arch Pharm (Weinheim) 2014;347:77-88
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceutica NV. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor. US20140038995; 2014
   Google Scholar
• Janssen Pharmaceutica NV. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor. US20130072510; 2013
   Google Scholar
• Bioprojet. Benzazole derivatives as histamine H4 receptor ligands. WO20120041860; 2012
   Google Scholar
• Bioprojet. Benzazole derivatives as histamine H4 receptor ligands. EP2447263; 2012
   Google Scholar
• Bioprojet. Benzazole derivatives as histamine H4 receptor ligands. CA2812686; 2012
   Google Scholar
• Bioprojet. Benzazole derivatives as histamine H4 receptor ligands. US20130231329; 2013
   Google Scholar
• Shionogi. Pharmaceutical composition containing fused hetero-ring derivative. US20120277238; 2012
   Google Scholar
• Wagner E, Wittmann HJ, Elz S, et al. Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor–H1/H4 receptor selectivity. Naunyn Schmiedebergs Arch Pharmacol 2014;387:235-50
   PubMed Web of Science ®Google Scholar
• Engelhardt H, de Esch IJ, Kuhn D, et al. Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. Eur J Med Chem 2012;54:660-8
   PubMed Web of Science ®Google Scholar
• Lane CA, Hay D, Mowbray CE, et al. Synthesis of novel histamine H4 receptor antagonists. Bioorg Med Chem Lett 2012;22:1156-9
   PubMed Web of Science ®Google Scholar
• Incyte Corp. Substituted heterocyclic compounds. US20130296327; 2013
   Google Scholar
• Incyte Corp. Substituted heterocyclic compounds. US20130244999; 2013
   Google Scholar
• Janssen Pharmaceutica NV. 2-aminopyrimidine modulators of the histamine. H4 receptor. US20130158259; 2013
   Google Scholar
• Janssen Pharmaceutica NV. 2-aminopyrimidine modulators of the histamine. H4 receptor. US20130158258; 2013
   Google Scholar
• Janssen Pharmaceutica NV. 2-aminopyrimidine modulators of the histamine. H4 receptor. EP2599386; 2013
   Google Scholar
• Janssen Pharmaceutica NV. Process for the preparation of substituted pyrimidine derivatives. US20140121374; 2014
   Google Scholar
• Savall BM, Chavez F, Tays K, et al. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. J Med Chem 2014;57:2429-39
   PubMed Web of Science ®Google Scholar
• Medicis Pharmaceutical Corp. Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists. US20130018031; 2013
   Google Scholar
• Schreeb A, Walter M, Odadzic D, et al. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands. Pharmazie 2013;68:521-5
   PubMed Web of Science ®Google Scholar
• Engelhardt H, Schultes S, de Graaf C, et al. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode. J Med Chem 2013;56:4264-76
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceutica NV. Thieno- and furo-pyrimidine modulators of the histamine H4 receptor. US20120270855; 2012
   Google Scholar
• Janssen Pharmaceutica NV. Thieno- and furo-pyrimidine modulators of the histamine H4 receptor. US20120238544; 2012
   Google Scholar
• Janssen Pharmaceutica NV. Thieno- and furo-pyrimidine modulators of the histamine H4 receptor. US20120208793; 2012
   Google Scholar
• Andaloussi M, Lim HD, van der Meer T, et al. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787. Bioorg Med Chem Lett 2013;23:2663-70
   PubMed Web of Science ®Google Scholar
• Arena Pharmaceutical, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds. WO20130151982; 2013
   Google Scholar
• Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO20110112766; 2011
   Google Scholar
• Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO20130039785; 2013
   Google Scholar
• Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. US20130245001; 2013
   Google Scholar
• Bioprojet. New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands. US20130324506; 2013
   Google Scholar
• Bioprojet. New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands. EP2671884; 2013
   Google Scholar
• Terrasse G. Use of a new histamine H4 agonist for the treatment of acute leukemia. US20130303565; 2013
   Google Scholar
• Loria E. Treatment of diseases modulated by a H4 receptor agonist. US20130059878; 2013
   Google Scholar
• ChEMBL database. 2014. Available from: https://www.ebi.ac.uk/chembl/ [Last accessed 18 July 2014]
   Google Scholar
• Mcule. 2014. Available from: https:\⊂\⊂mcule.com [Last accessed 18 July 2014]
   Google Scholar
• Hopkins AL, Keserű GM, Leeson PD, et al. The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 2014;13:105-21
   PubMed Web of Science ®Google Scholar
• Tarcsay A, Nyíri K, Keserű GM. Impact of lipophilic efficiency on compound quality. J Med Chem 2012;55:1252-60
   PubMed Web of Science ®Google Scholar
• Wager TT, Chandrasekaran RY, Hou X, et al. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem Neurosci 2010;1:420-34
   PubMed Web of Science ®Google Scholar
• Project information: UR-63325. 2014. Available from: http://www.histamineresearch.com/Reports/Palau_Pharma_H4.pdf [Last accessed 19 July 2014]
   Google Scholar
• Hann MM, Leach AR, Harper G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 2001;41:856-64
   PubMedGoogle Scholar